Human embryonic stem cells have been defined as self-renewing cells that can give rise to
many types of cells of the body. How and whether these cells can be manipulated to replace …

Human pluripotent stem cells are known to have the capacity to renew indefinitely, being
intrinsically able to differentiate into many different cell types. These characteristics have …

Embryonic stem (ES) cells have the potential to serve as an alternative source of
hematopoietic precursors for transplantation and for the study of hematopoietic cell …

Stem cells, derived from human adult dental pulp of healthy subjects 30‐45 years of age,
were cultured, and cells were selected using a FACSorter. A new c‐kit+/CD34+/CD45− cell …

Human induced pluripotent stem (iPS) cells derived from somatic cells hold promise to
develop novel patient-specific cell therapies and research models for inherited and acquired …

The clinical use of human pluripotent stem cells and their derivatives is limited by the
rejection of transplanted cells due to differences in their human leukocyte antigen (HLA) …

Background Human embryonic stem (hES) cells are a promising source for transplantation
to replace diseased or damaged tissue, but their differentiated progeny express human …

Differentiated cell types derived from human embryonic stem cells (hESCs) may serve in the
future to treat various human diseases. A crucial step toward their successful clinical …

Stem cells were obtained from deciduous dental pulp of healthy subjects, aged 6–10 years.
This stem cell population was cultured, expanded, and specifically selected, detecting using …

It was reported recently that human fibroblasts can be reprogrammed into a pluripotent state
that resembles that of human embryonic stem (hES) cells. This was achieved by ectopic …